Core Viewpoint - Rosen Law Firm is reminding purchasers of Telix Pharmaceuticals Ltd. securities about the upcoming lead plaintiff deadline for a securities class action lawsuit, indicating potential compensation for eligible investors [1] Summary by Relevant Sections - Company Information - Telix Pharmaceuticals Ltd. is involved in a securities class action lawsuit for transactions that occurred between February 21, 2025, and August 28, 2025 [1] - Legal Action Details - The lead plaintiff deadline for the class action is set for January 9, 2026, highlighting the importance of timely action for affected investors [1] - Investor Implications - Investors who purchased Telix securities during the specified class period may be entitled to compensation without any out-of-pocket expenses [1]
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX